Gene Therapy for CNS Disorders Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
This report elaborates the market size, market characteristics, and market growth of the Gene Therapy for CNS Disorders industry, and breaks down according to the type, application, and consumption area of Gene Therapy for CNS Disorders. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Gene Therapy for CNS Disorders in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Gene Therapy for CNS Disorders market covered in Chapter 13:
Biogen
bluebird bio, Inc.
Novartis AG
Pfizer Inc.
Roche (Spark Therapeutics)
Voyager Therapeutics
In Chapter 6, on the basis of types, the Gene Therapy for CNS Disorders market from 2015 to 2025 is primarily split into:
AAV
Adenovirus
In Chapter 7, on the basis of applications, the Gene Therapy for CNS Disorders market from 2015 to 2025 covers:
SMA
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Gene Therapy for CNS Disorders Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Gene Therapy for CNS Disorders Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Gene Therapy for CNS Disorders Market Forces
3.1 Global Gene Therapy for CNS Disorders Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Gene Therapy for CNS Disorders Market - By Geography
4.1 Global Gene Therapy for CNS Disorders Market Value and Market Share by Regions
4.1.1 Global Gene Therapy for CNS Disorders Value ($) by Region (2015-2020)
4.1.2 Global Gene Therapy for CNS Disorders Value Market Share by Regions (2015-2020)
4.2 Global Gene Therapy for CNS Disorders Market Production and Market Share by Major Countries
4.2.1 Global Gene Therapy for CNS Disorders Production by Major Countries (2015-2020)
4.2.2 Global Gene Therapy for CNS Disorders Production Market Share by Major Countries (2015-2020)
4.3 Global Gene Therapy for CNS Disorders Market Consumption and Market Share by Regions
4.3.1 Global Gene Therapy for CNS Disorders Consumption by Regions (2015-2020)
4.3.2 Global Gene Therapy for CNS Disorders Consumption Market Share by Regions (2015-2020)
5 Gene Therapy for CNS Disorders Market - By Trade Statistics
5.1 Global Gene Therapy for CNS Disorders Export and Import
5.2 United States Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.3 Europe Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.4 China Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.5 Japan Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.6 India Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.7
6 Gene Therapy for CNS Disorders Market - By Type
6.1 Global Gene Therapy for CNS Disorders Production and Market Share by Types (2015-2020)
6.1.1 Global Gene Therapy for CNS Disorders Production by Types (2015-2020)
6.1.2 Global Gene Therapy for CNS Disorders Production Market Share by Types (2015-2020)
6.2 Global Gene Therapy for CNS Disorders Value and Market Share by Types (2015-2020)
6.2.1 Global Gene Therapy for CNS Disorders Value by Types (2015-2020)
6.2.2 Global Gene Therapy for CNS Disorders Value Market Share by Types (2015-2020)
6.3 Global Gene Therapy for CNS Disorders Production, Price and Growth Rate of AAV (2015-2020)
6.4 Global Gene Therapy for CNS Disorders Production, Price and Growth Rate of Adenovirus (2015-2020)
7 Gene Therapy for CNS Disorders Market - By Application
7.1 Global Gene Therapy for CNS Disorders Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Gene Therapy for CNS Disorders Consumption by Applications (2015-2020)
7.1.2 Global Gene Therapy for CNS Disorders Consumption Market Share by Applications (2015-2020)
7.2 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2015-2020)
7.3 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2015-2020)
8 North America Gene Therapy for CNS Disorders Market
8.1 North America Gene Therapy for CNS Disorders Market Size
8.2 United States Gene Therapy for CNS Disorders Market Size
8.3 Canada Gene Therapy for CNS Disorders Market Size
8.4 Mexico Gene Therapy for CNS Disorders Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Gene Therapy for CNS Disorders Market Analysis
9.1 Europe Gene Therapy for CNS Disorders Market Size
9.2 Germany Gene Therapy for CNS Disorders Market Size
9.3 United Kingdom Gene Therapy for CNS Disorders Market Size
9.4 France Gene Therapy for CNS Disorders Market Size
9.5 Italy Gene Therapy for CNS Disorders Market Size
9.6 Spain Gene Therapy for CNS Disorders Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Gene Therapy for CNS Disorders Market Analysis
10.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size
10.2 China Gene Therapy for CNS Disorders Market Size
10.3 Japan Gene Therapy for CNS Disorders Market Size
10.4 South Korea Gene Therapy for CNS Disorders Market Size
10.5 Southeast Asia Gene Therapy for CNS Disorders Market Size
10.6 India Gene Therapy for CNS Disorders Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Gene Therapy for CNS Disorders Market Analysis
11.1 Middle East and Africa Gene Therapy for CNS Disorders Market Size
11.2 Saudi Arabia Gene Therapy for CNS Disorders Market Size
11.3 UAE Gene Therapy for CNS Disorders Market Size
11.4 South Africa Gene Therapy for CNS Disorders Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Gene Therapy for CNS Disorders Market Analysis
12.1 South America Gene Therapy for CNS Disorders Market Size
12.2 Brazil Gene Therapy for CNS Disorders Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Biogen
13.1.1 Biogen Basic Information
13.1.2 Biogen Product Profiles, Application and Specification
13.1.3 Biogen Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.2 bluebird bio, Inc.
13.2.1 bluebird bio, Inc. Basic Information
13.2.2 bluebird bio, Inc. Product Profiles, Application and Specification
13.2.3 bluebird bio, Inc. Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.3 Novartis AG
13.3.1 Novartis AG Basic Information
13.3.2 Novartis AG Product Profiles, Application and Specification
13.3.3 Novartis AG Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Basic Information
13.4.2 Pfizer Inc. Product Profiles, Application and Specification
13.4.3 Pfizer Inc. Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.5 Roche (Spark Therapeutics)
13.5.1 Roche (Spark Therapeutics) Basic Information
13.5.2 Roche (Spark Therapeutics) Product Profiles, Application and Specification
13.5.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.6 Voyager Therapeutics
13.6.1 Voyager Therapeutics Basic Information
13.6.2 Voyager Therapeutics Product Profiles, Application and Specification
13.6.3 Voyager Therapeutics Gene Therapy for CNS Disorders Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.2 Europe Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.3 Asia-Pacific Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.4 Middle East and Africa Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.5 South America Gene Therapy for CNS Disorders Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Gene Therapy for CNS Disorders Market Forecast by Types (2020-2025)
15.1.1 Global Gene Therapy for CNS Disorders Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Gene Therapy for CNS Disorders Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Gene Therapy for CNS Disorders Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Gene Therapy for CNS Disorders Picture
Table Gene Therapy for CNS Disorders Key Market Segments
Figure Study and Forecasting Years
Figure Global Gene Therapy for CNS Disorders Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Gene Therapy for CNS Disorders Value ($) and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Value ($) by Countries (2015-2020)
Table Global Gene Therapy for CNS Disorders Value Market Share by Regions (2015-2020)
Figure Global Gene Therapy for CNS Disorders Value Market Share by Regions in 2019
Figure Global Gene Therapy for CNS Disorders Production and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Production by Major Countries (2015-2020)
Table Global Gene Therapy for CNS Disorders Production Market Share by Major Countries (2015-2020)
Figure Global Gene Therapy for CNS Disorders Production Market Share by Regions in 2019
Figure Global Gene Therapy for CNS Disorders Consumption and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption by Regions (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Regions (2015-2020)
Figure Global Gene Therapy for CNS Disorders Consumption Market Share by Regions in 2019
Table Global Gene Therapy for CNS Disorders Export Top 3 Country 2019
Table Global Gene Therapy for CNS Disorders Import Top 3 Country 2019
Table United States Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Europe Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table China Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Japan Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table India Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Global Gene Therapy for CNS Disorders Production by Types (2015-2020)
Table Global Gene Therapy for CNS Disorders Production Market Share by Types (2015-2020)
Figure Global Gene Therapy for CNS Disorders Production Share by Type (2015-2020)
Table Global Gene Therapy for CNS Disorders Value by Types (2015-2020)
Table Global Gene Therapy for CNS Disorders Value Market Share by Types (2015-2020)
Figure Global Gene Therapy for CNS Disorders Value Share by Type (2015-2020)
Figure Global AAV Production and Growth Rate (2015-2020)
Figure Global AAV Price (2015-2020)
Figure Global Adenovirus Production and Growth Rate (2015-2020)
Figure Global Adenovirus Price (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption by Applications (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Applications (2015-2020)
Figure Global Gene Therapy for CNS Disorders Consumption Share by Application (2015-2020)
Figure Global SMA Consumption and Growth Rate (2015-2020)
Figure Global Others Consumption and Growth Rate (2015-2020)
Figure North America Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table North America Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table North America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure North America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure United States Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Canada Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Mexico Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Europe Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Europe Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Europe Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Germany Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure France Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Italy Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Spain Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Asia-Pacific Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure China Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Japan Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South Korea Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure India Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Middle East and Africa Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure UAE Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South Africa Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South America Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table South America Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table South America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure South America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Brazil Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Biogen Company Profile
Table Biogen Production, Value, Price, Gross Margin 2015-2020
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table bluebird bio, Inc. Company Profile
Table bluebird bio, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure bluebird bio, Inc. Production and Growth Rate
Figure bluebird bio, Inc. Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Roche (Spark Therapeutics) Company Profile
Table Roche (Spark Therapeutics) Production, Value, Price, Gross Margin 2015-2020
Figure Roche (Spark Therapeutics) Production and Growth Rate
Figure Roche (Spark Therapeutics) Value ($) Market Share 2015-2020
Table Voyager Therapeutics Company Profile
Table Voyager Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Voyager Therapeutics Production and Growth Rate
Figure Voyager Therapeutics Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Production by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Production Share by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Value ($) by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Value Share by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Consumption by Applications (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Consumption Share by Applications (2020-2025)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|